259 filings
Page 3 of 13
8-K
111frkvyw e5bzc9v
6 May 21
Other Events
10:12am
8-K
0n8bx1ctf 8uw
15 Mar 21
Breakthrough Patent-pending Tracer Developed for Broad Use
10:39am
N-CEN
k46bu1u 6j
15 Mar 21
Annual report (registered investment company)
6:07am
N-CSR
q35mbsuw7p5g
25 Feb 21
Certified annual shareholder report (management investment company)
5:26pm
8-K
hd3oe8s1mas
5 Oct 20
Other Events
9:03am
S-8
mxss46w2p5g66n2dq
16 Sep 20
Registration of securities for employees
4:48pm
N-PX
18xc1g9zreb18ca6nvpy
1 Sep 20
Annual report of proxy voting record
12:00am
N-CSRS
1pr tab04swnw0j1cfq
21 Aug 20
Certified semi-annual shareholder report (management investment company)
5:23pm
8-K
8fh9bdre1s8
21 Jul 20
Daxor Corporation Announces Pricing of $7.0 Million Registered Direct Offering
8:43am
8-K
1hc8jb47au3
16 Jul 20
Daxor Announces Prospective Randomized Control Trial at Duke University Medical Center to Guide Volume Treatment In Heart Failure Patients
9:02am
8-K
au77gsb1p6ihv97
15 Jul 20
Daxor Announces Initiation of First-of-It’s-Kind Multicenter BVA-100® Study in Hospitalized Patients with COVID-19
3:53pm
EFFECT
duhipqs0rcnwmajwqqnd
15 Jul 20
Notice of effectiveness
12:15am
CORRESP
aq6f6u8
13 Jul 20
Correspondence with SEC
12:00am
8-K
5kbx6 cjr9
1 Jul 20
Daxor Corporation Announces Appointment of Henry D. Cremisi, MD, FACP and Joy Goudie, Esq. to the Company’s Board of Directors
4:49pm
8-K
lvo755mqyqxj a1cmpcj
6 May 20
Other Events
5:07pm
8-K
v8fp4s t8xzgzlpmnpa
23 Apr 20
Other Events
5:12pm
N-CEN
8vap5mmn
13 Mar 20
Annual report (registered investment company)
5:28pm
N-CSR
7eoli8t
28 Feb 20
Certified annual shareholder report (management investment company)
5:05pm